If slow muscle recovery or a strain that keeps coming back has you asking whether a doctor can now get you TB-500, here is the short answer. HHS's interim policy describes conditions under which it does not intend to take enforcement action against a licensed pharmacy or physician compounding TB-500. The policy had not been published or given an effective date as of October 28, 2026, so check the Federal Register. TB-500 is not FDA-approved, and the human evidence for muscle recovery is thin.
Can a doctor prescribe TB-500 for muscle recovery now?
You may have seen the claim that doctors can now prescribe TB-500 at their own discretion. That is not quite the change. According to HHS, TB-500 was in category 2 of FDA's FDA list of bulk substances that may present significant safety risks from September 29, 2023 until April 22, 2026. That FDA page still lists TB-500 with the safety concerns quoted below. The HHS policy document says HHS does not intend to act against a State-licensed pharmacy, Federal facility or licensed physician that compounds TB-500 under the conditions below. It had not been published or given an effective date as of October 28, 2026.
Compounding still requires a prescription for you as an individual. The federal pharmacy compounding statute describes compounded products made for an identified patient based on a valid prescription order.
The HHS enforcement policy on peptide compounding sets these conditions for TB-500:
| Condition | What it means for you |
|---|---|
| A valid, patient-specific prescription | The compound is made for you, not sold off a shelf. |
| Injection only | TB-500 is limited to subcutaneous or intramuscular injection. |
| Ingredient from an FDA-registered original manufacturer with a valid certificate of analysis | Ask which manufacturer supplies the ingredient and request the certificate. |
| One peptide per product | Blends of two or more peptides in one product are outside the policy. |
| Serious side effects and quality problems reported to FDA MedWatch and to the states | Problems with the product are meant to reach regulators. |
| Label reads “This is a compounded drug product. Not for resale.” | Check the label before you accept the product. |
| Only device is an FDA 510(k)-cleared syringe | No other delivery device should come with the product. |
HHS states that “Compounded drugs are not FDA-approved.” It also says it may revisit the policy if a safety signal or quality issue arises.
The policy covers six peptides listed in its Appendix A: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500. A research-use-only vial is not covered by the policy, and neither is a vial that mixes TB-500 with BPC-157.
The policy is interim. The OIRA record showed it unpublished as of October 28, and the HHS document carries no effective date, so check the Federal Register for the official notice.
| Date | What happened |
|---|---|
| September 29, 2023 | TB-500 enters category 2 of FDA's list, according to HHS. |
| April 22, 2026 | TB-500's category 2 period ends, according to HHS. CDER had recommended against listing it. |
| July 23 to 24, 2026 | FDA's Pharmacy Compounding Advisory Committee meets. ABC News reports the panel narrowly voted to recommend adding TB-500 to the list. |
| October 14, 2026 | FDA's interim policy goes to the Office of Information and Regulatory Affairs (OIRA) at the Office of Management and Budget. |
| October 27, 2026 | OIRA completes its review. Its review record lists the decision as “Consistent with Change.” |
What is TB-500?
FDA lists TB-500 as “Thymosin beta-4, fragment (LKKTETQ), also known as TB-500.” Thymosin beta-4 is a 43-amino-acid peptide found in humans and animals. According to All About Peptides, TB-500 is made in the lab with a shorter chain of amino acids.
What are the potential benefits of TB-500?
TB-500 is marketed for recovery and tissue repair. Peptide sellers describe it in broad terms. All About Peptides says it “is great for musculoskeletal and dermal damages that are hard to recover.” The seller Swolverine says TB-500 “plays a vital role in soft tissue regeneration, especially in tendons, ligaments, and muscle fibers.”
The research cited on those pages is limited. Here is what each claim rests on.
| Claim | Who makes it | The research behind it |
|---|---|---|
| Increased muscle-regenerating fibers | All About Peptides | A preclinical study in mice |
| Helps form new blood vessels | All About Peptides | Preclinical research |
| Helps fight infections by encouraging T cells | All About Peptides | An animal study |
Does TB-500 help you build muscle?
Some peptides, like insulin and GLP-1s, are FDA-approved medicines that have been rigorously tested. Others have grown popular online. An ABC News report on the July advisory vote says these others “exploded in popularity online despite a lack of robust data, with influencers suggesting they can help build muscle, improve metabolism and more.”
FDA says it has not identified any human exposure data for drug products containing TB-500, and ABC News reports a lack of robust data for these peptides.
For the basics of rest and recovery between sessions, read muscle recovery 101. If you are weighing supplements instead, Muscle Recovery and Supplements covers the options people reach for.
How strong is the human evidence for TB-500?
Human evidence for TB-500 in muscle recovery is thin. The studies in the claims table above are animal or preclinical studies. FDA's FDA list of bulk substances with safety risks says FDA “has not identified any human exposure data” for drug products containing TB-500.
HHS's policy describes the safety concerns as “inferential rather than observed.” It says the parent protein “has a controlled human safety record across several routes,” and that the TB-500 fragment “is rapidly truncated in human serum.”
The advisory vote was not unanimous. The Hill reports that FDA staff concluded there was not enough evidence to support adding any of the six peptides, and that the committee vote was split nearly evenly.
Is TB-500 safe, and what are its side effects?
FDA's list says TB-500 “may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation as well as peptide-related impurities.” It also says FDA “lacks important information regarding any safety issues raised by this drug, including whether it would cause harm if administered to humans.”
All About Peptides lists these side effects:
| Side effect (as listed by All About Peptides) |
|---|
| Pain and redness at the injection site |
| Lightheadedness |
| Mild headache |
| Nausea |
| Fatigue |
| Unwanted hair growth |
| Allergic reaction (rare) |
The same page says severe reactions such as fever or anaphylaxis need a healthcare provider's attention. It also notes that research on TB-500 and cancer gives contrasting results.
Who should avoid TB-500?
All About Peptides lists these as reasons to avoid TB-500:
- A history of cancer or any autoimmune disorder
- Pregnancy or breastfeeding
- Competitive sport with drug or peptide testing
- Taking blood thinners or other drugs that can interact with it
If any of these describe you, raise it with your prescriber before anything else.
Is TB-500 banned in sports?
Swolverine's guide, a seller's page, says TB-500 is banned by WADA and listed under S2, and that it is “Prohibited at all times (in and out of competition).” It also says USADA, NCAA and IOC enforce the ban. If you are drug-tested, check your testing body's rules before anything else.
Is there a TB-500 dosage calculator or dosage chart?
Swolverine's guide says that because TB-500 is sold as a research peptide, there are “no standardized medical dosing guidelines.” Dosing is a decision for your prescriber, not a calculator.
A vial sold as research-use-only is outside the policy. That means it does not carry the pharmacy, prescription and labeling conditions above.
What are your options?
1. Talk to a prescriber, in person or by telehealth. Ask whether TB-500 fits your situation under the policy. These are questions worth bringing, as our own suggestions:
- Which pharmacy will compound it, and is it state-licensed?
- Which FDA-registered manufacturer supplies the ingredient, and can I see the certificate of analysis?
- Does the label read “This is a compounded drug product. Not for resale.”?
- Is it a single peptide, delivered with an FDA 510(k)-cleared syringe?
- Which established treatments fit my injury, and how does TB-500 compare?
2. Ask about established treatments. TB-500 is not FDA-approved. Your prescriber can tell you which established treatments fit your injury.
3. Wait for a final rule. An Associated Press report, carried by ABC News, says formally adding peptides to FDA's list would require federal rulemaking, “a process that could take years.”
A citizen petition from the Partnership for Safe Medicines asks FDA not to allow compounding of six peptides, including TB-500. The group says it bought five vials of unapproved peptides from telehealth services, and that none of the businesses had licenses to dispense injectables in California.
Your next step is small. Write down your injury, how long it has lasted and the questions above, then bring them to a prescriber.
By the Gym Floor Guide Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.